Raúl R. Quiñonez-López
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Raúl R. Quiñonez-López has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Eulogio Orozco-Guareño
Departamento de Quimica, Centro Universitario de Ciencias Exactas e Ingenierias, Universidad de Guadalajara, Guadalajara 44430, Mexico
1 shared publication - Gerardo León-Sánchez
Departamento de Procesos Tecnológicos e Industriales, Instituto Tecnológico de Estudios Superiores de Occidente, Periférico Sur Manuel Gómez Morín # 8585, Guadalajara 45604, Jalisco, Mexico
1 shared publication - Jesús Baudelio Campos-García
Departamento de Química, Centro de Ciencias Básicas, Universidad Autónoma de Aguascalientes, Av. Universidad #940, Ciudad Universitaria, Aguascalientes 20100, Aguascalientes, Mexico
1 shared publication - Luisa Fernanda Briones-Márquez
Chemical Engineering Department, University Center of Exact Sciences and Engineering (CUCEI), University of Guadalajara, Guadalajara 44430, Jalisco, Mexico
1 shared publication - María de Jesús Palacios-Sánchez
Laboratorio de Fisicoquímica, Departamento de Química, Centro Universitario de Ciencias Exactas e Ingenierías, Universidad de Guadalajara, Blvd. Marcelino García Barragán #1421, esq. Calzada Olímpica, Guadalajara 44430, Jalisco, Mexico
1 shared publication - Oscar Guillermo Zúñiga-González
Departamento de Ingeniería Biológica, Sintética y de Materiales, Centro Universitario de Tlajomulco, Universidad de Guadalajara, Carretera Tlajomulco, Santa Fé Km. 3.5 No. 595 Lomas de Tejeda, Tlajomulco de Zúñiga 45641, Jalisco, Mexico
1 shared publication
Latest Publications
- Open Access
Semicontinuous Microemulsion Polymerization of Polymeric Nanoparticles of Poly(cyanoacrylates) and Poly(caprolactone)
Polymeric nanoparticles based on poly(ethyl cyanoacrylate) (PECA) and poly(ε-caprolactone) (PCL) were synthesized via semicontinuous microemulsion polymerization for potential biomedical applications. A systematic evaluation of four surfactants (Tween 80, Alkonat L70, Genapol LRO, and Brij-20) was carried out to determine their effects on micelle formation and particle size. Brij-20 enabled the formation of nanoparticles under 100 nm, with optimal conditions identified at 4% surfactant concentration and pH 1.75. The polymerization process included acid-catalyzed ring-opening of ε-caprolactone, followed by the semicontinuous addition of ethyl-2-cyanoacrylate under an inert atmosphere. Copolymerization was confirmed through FT-IR spectroscopy, nuclear magnetic resonance (NMR) spectroscopy, and differential scanning calorimetry, revealing a glass transition temperature (Tg) of 110.9 °C, indicating PECA as the dominant phase. Thermogravimetric analysis showed two decomposition events corresponding to each polymer. Transmission electron microscope analysis revealed nanoparticles averaging 51.74 nm in diameter. These findings demonstrate the feasibility of producing PECA-PCL nanoparticles with controlled size and composition, suitable for drug delivery and other biomedical uses.
Open AccessSemicontinuous Microemulsion Polymerization of Polymeric Nanoparticles of Poly(cyanoacrylates) and Poly(caprolactone)
Polymeric nanoparticles based on poly(ethyl cyanoacrylate) (PECA) and poly(ε-caprolactone) (PCL) were synthesized via semicontinuous microemulsion polymerization for potential biomedical applications. A systematic evaluation of four surfactants (Tween 80, Alkonat L70, Genapol LRO, and Brij-20) was carried out to determine their effects on micelle formation and particle size. Brij-20 enabled the formation of nanoparticles under 100 nm, with optimal conditions identified at 4% surfactant concentration and pH 1.75. The polymerization process included acid-catalyzed ring-opening of ε-caprolactone, followed by the semicontinuous addition of ethyl-2-cyanoacrylate under an inert atmosphere. Copolymerization was confirmed through FT-IR spectroscopy, nuclear magnetic resonance (NMR) spectroscopy, and differential scanning calorimetry, revealing a glass transition temperature (Tg) of 110.9 °C, indicating PECA as the dominant phase. Thermogravimetric analysis showed two decomposition events corresponding to each polymer. Transmission electron microscope analysis revealed nanoparticles averaging 51.74 nm in diameter. These findings demonstrate the feasibility of producing PECA-PCL nanoparticles with controlled size and composition, suitable for drug delivery and other biomedical uses.